Title : Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia.

Pub. Date : 2017 Jun

PMID : 28478132






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND AND AIMS: We aimed to assess the effects of cholesteryl ester transfer protein inhibitor anacetrapib added to statin +- other lipid-modifying therapies (LMT) in Japanese patients with dyslipidemia who were not at their LDL-C goal. anacetrapib cholesteryl ester transfer protein Homo sapiens